Pathways for internalization and recycling of the chemokine receptor CCR5

Mueller, Anja ORCID:, Kelly, Eamonn and Strange, Philip G. (2002) Pathways for internalization and recycling of the chemokine receptor CCR5. Blood, 99 (3). pp. 785-791. ISSN 0006-4971

Full text not available from this repository. (Request a copy)


M-tropic human immunodeficiency virus (HIV-1) strains enter the cell after interaction with their receptors, CD4 and the G-protein-coupled chemokine receptor CCR5. The number of cell surface CCR5 molecules is thought to be important in determining the infection rate for HIV. Cell surface CCR5 is dependent on the rate of receptor internalization and recycling. Internalization of G-protein-coupled receptors after agonist activation is thought to occur either through clathrin-coated pits or through caveolae. In this study, the role of these different pathways was investigated in Chinese hamster ovary cells expressing CCR5 using specific inhibitors. Internalization of CCR5 after chemokine treatment was inhibited by sucrose, indicating a role for the clathrin-coated pit pathway. Activation of CCR5 leads to arrestin-2 movement in the cells, providing further evidence for the involvement of clathrin-coated pits. Nystatin and filipin also affected the rate of internalization of CCR5, indicating a role for caveolae. Using inhibitors of vesicle transport in the cell, it was found that the CCR5 recycling pathway is independent of the Golgi apparatus and late endosomes. Protein synthesis is not involved in receptor recovery. It seems likely that after internalization, CCR5 is directed to early endosomes and subsequently recycled to the cell surface. (C) 2002 by The American Society of Hematology.

Item Type: Article
Uncontrolled Keywords: sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School: Faculty of Science > School of Pharmacy
UEA Research Groups: Faculty of Science > Research Groups > Molecular and Tissue Pharmacology
Faculty of Science > Research Groups > Pharmaceutical Cell Biology (former - to 2017)
Depositing User: Rachel Smith
Date Deposited: 31 May 2011 14:45
Last Modified: 24 Oct 2022 03:22
DOI: 10.1182/blood.V99.3.785

Actions (login required)

View Item View Item